| Code | Target | Indication | Combination | Early study | CMC | Pre-clinical | IIT | IND | Phase 1 | Phase 2 |
| MT020 | CD19 | AID | ||||||||
| MT026 | IL13Rα2 | Recurrent Gliomas | ||||||||
| MT027 | B7-H3 | Recurrent Gliomas | ||||||||
| Recurrent Gliomas | +Bevacizumab | |||||||||
| First Diagnosis of Glioma | Adjuvant Therapy | |||||||||
| Thoracic Mesothelioma | ||||||||||
| Brain Metastases | ||||||||||
| Abdorminal Metastases |